Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Fertility and Sterility|June 15, 2004
The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transitionFrederick Naftolin, Hugh S Taylor, Richard Karas, et al.
Menopause (New York, N.Y.)|February 23, 2011
The Timing Hypothesis remains a valid explanation of differential cardioprotective effects of menopausal hormone treatmentSeung Do Choi, Emma M Steinberg, Hae Hyeog Lee, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 16, 2006
Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesisJohn R Pepperell, Gabor Nemeth, Yuji Yamada, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 1, 2013
The Women's Health Initiative trial and related studies: 10 years later: a clinician's viewElizabeth P Gurney, Margaret J Nachtigall, Lila E Nachtigall, et al.
Endocrinology|April 19, 2008
Estradiol-induced synaptic remodeling of tyrosine hydroxylase immunopositive neurons in the rat arcuate nucleusEszter Csakvari, Anita Kurunczi, Zsofia Hoyk, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 6, 2012
Ezrin overexpression by transformed human ovarian surface epithelial cells, ovarian cleft cells, and serous ovarian adenocarcinoma cellsAhmed Fadiel, Zhaocong Chen, Emine Ulukus, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|September 27, 2014
Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12A Fadiel, J Song, D Tivon, et al.
The Journal of Clinical Endocrinology and Metabolism|July 16, 2009
Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and menThomas Münzer, S Mitchell Harman, John D Sorkin, et al.
Pageof 15